Your browser doesn't support javascript.
loading
Switching regimens in virologically suppressed HIV-1-infected patients: evidence base and rationale for integrase strand transfer inhibitor (INSTI)-containing regimens.
Raffi, F; Esser, S; Nunnari, G; Pérez-Valero, I; Waters, L.
Affiliation
  • Raffi F; Infectious Diseases Department, University Hospital Hotel Dieu, Nantes, France. francois.raffi@wanadoo.fr.
  • Esser S; Department of Dermatology and Venerology, University HIV/STD Center Essen, University Hospital Essen, Essen, Germany.
  • Nunnari G; Unit of Infectious Diseases, Department of Clinical and Experimental Medicine, Policlinico 'G. Martino', University of Messina, Messina, Italy.
  • Pérez-Valero I; IdiPAZ, La Paz University Hospital, Madrid, Spain.
  • Waters L; Mortimer Market Centre, Central & North West London NHS Trust, London, UK.
HIV Med ; 17 Suppl 5: 3-16, 2016 10.
Article in En | MEDLINE | ID: mdl-27714978
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 / HIV Integrase Inhibitors / Antiretroviral Therapy, Highly Active / Sustained Virologic Response Type of study: Guideline Limits: Humans Language: En Journal: HIV Med Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2016 Document type: Article Affiliation country: France Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 / HIV Integrase Inhibitors / Antiretroviral Therapy, Highly Active / Sustained Virologic Response Type of study: Guideline Limits: Humans Language: En Journal: HIV Med Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2016 Document type: Article Affiliation country: France Country of publication: United kingdom